Followers | 130 |
Posts | 18112 |
Boards Moderated | 0 |
Alias Born | 01/16/2007 |
Wednesday, October 28, 2020 2:49:41 PM
What Is SEC Form 10?
SEC Form 10 is a filing with the Securities and Exchange Commission (SEC), also known as the General Form for Registration of Securities. It is used to register a class of securities for potential trading on U.S. exchanges. Any company with over $10 million in total assets and 750 or more shareholders is required to file a Form 10 with the SEC.
The filing of SEC Form 10 is a necessary but insufficient step to register securities for trading. Financial Industry Regulatory Authority (FINRA) must approve the trading of the securities.
Any company under these thresholds may file a Form 10 voluntarily. The Form 10 registration statement automatically becomes effective sixty days post-filing.
The Elements of SEC Form 10
* Business
* Risk Factors
* Financial Information
* Properties
* Security Ownership of Certain Beneficial Owners and Management
* Directors and Executive Officers
* Executive Compensation
* Certain Relationships and Related Transactions, and Director Independence
* Legal Proceedings
* Market Price of and Dividends on the Registrant's Common Equity and Related Stockholder Matters
* Recent Sales of Unregistered Securities
* Description of Registrant's Securities to be Registered
* Indemnification of Directors and Officers
* Financial Statements and Supplementary Data
* Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
* Financial Statements and Exhibits
https://www.investopedia.com/terms/s/sec-form-10.asp
4 Pages Of Form 10
https://www.sec.gov/files/form10.pdf
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM